Orfonyx Bio
PrivateLast Round
Seed
Apr 9, 2025
Company Overview
Orfonyx Bio is a biotechnology company developing a new class of genetic medicines that enhance gene expression by targeting regulatory elements in untranslated regions of genes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orfonyx Bio Comparables
Compare Orfonyx Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ribometrix | 86% | |
| Rgenta Therapeutics | 79% | |
| Ochre Bio | 78% | |
Orfonyx Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 9, 2025 |
Key People
Founding team and executive leadership
Orfonyx Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oxford Science Enterprises | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2025
Grew 43% QoQ from 7 to 10 employees.
- Oct 24, 2024
Grew 75% QoQ from 4 to 7 employees.
Orfonyx Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Orfonyx Bio's valuation, stock price, and market status.